［1］Sterne-Marr R, Gurevich VV, Goldsmith P, et al.Polypeptide variants of beta-arrestin and arrestin3［J］.J Biol Chem,1993,268(21):15640-15648.
［2］Oakley RH, Laporte SA, Holt JA, et al.Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors［J］.J Biol Chem,2000,275(22):17201-17210.
［3］Ferguson SS, Downey WE 3rd, Colapietro AM, et al. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization ［J］. Science, 1996, 271 (5247):363-366.
［4］Bryja V, Schambony A, Cajánek L, et al. Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways［J］.EMBO Rep,2008,9(12):1244-1250.
［5］Chen W, ten Berge D, Brown J, et al. Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4［J］. Science,2003,301(5638):1391-1394.
［6］Chen W, Kirkbride KC, How T,et al. Beta-arrestin 2 mediates endocytosis of type Ⅲ TGF-beta receptor and down-regulation of its signaling［J］.Science, 2003,301(5638):1394-1397.
［7］Mukherjee A, Veraksa A, Bauer A, et al. Regulation of Notch signalling by non-visual betaarrestin ［J］.Nat Cell Biol,2005,7(12):1191-1201.
［8］Barnes WG, Reiter E, Violin JD, et al. Beta-arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation［J］.J Biol Chem,2005,280 (9): 8041-8050.
［9］Zoudilova M, Kumar P, Ge L,et al. Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2［J］.J Biol Chem,2007,282(28):20634-20646.
［10］Gao H, Sun Y, Wu Y, et al. Identification of beta-arrestin 2 as a G protein-coupled receptor-stimulated regulator of NF-kappa B pathways［J］.Mol Cell,2004,14(3):303-317.
［11］Witherow DS, Garrison TR, Miller WE, et al. Beta-arrestin inhibits NF-kappa B activity by means of its interaction with the NF-kappa B inhibitor Ikappa B alpha［J］.Proc Natl Acad Sci USA, 2004,101(23):8603-8607.
［12］Li TT, Alemayehu M, Aziziyeh AI, et al. Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells［J］. Mol Cancer Res, 2009,7 (7) :1064-1077.
［13］Michal AM, Peck AR, Tran TH, et al. Differential expression of arrestins is a predictor of breast cancer progression and survival［J］.Breast Cancer Res Treat,2011,130(3):791-807.
［14］Dasgupta P, Rastogi S, Pillai S, et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways［J］.J Clin Invest,2006,116(8): 2208-2217.
［15］Raghuwanshi SK, Nasser MW, Chen X, et al. Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer［J］.J Immunol, 2008, 180 (8) :5699-5706.
［16］Sun X, Zhang Y, Wang J, et al. Beta-arrestin 2 modulates resveratrol-induced apoptosis and regulation of Akt/GSK3β pathways［J］.Biochim Biophys Acta, 2010,1800(9):912-918.
［17］Zhao M, Zhou G, Zhang Y, et al. Beta-arrestin 2 inhibits opioid-induced breast cancer cell death through Akt and Caspase-8 pathways［J］.Neoplasma,2009,56(2):108-113.
［18］Rosanò L, Cianfrocca R, Masi S, et al. Beta-arrestin links endothelin a receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis［J］.Proc Natl Acad Sci USA,2009, 106(8):2806-2811. 
［19］Kim JI, Lakshmikanthan V, Frilot N, et al. Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome［J］.Mol Cancer Res,2010,8(4):569-577.
［20］Mythreye K, Blobe GC. The type Ⅲ TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42 ［J］.Proc Natl Acad Sci USA,2009,106(20):8221-8226.
［21］Zou L, Yang R, Chai J,et al. Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis［J］.FASEB J,2008,22(2):355-364.
［22］Benovic JL, Kühn H, Weyand I,et al. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein)［J］.Proc Natl Acad Sci U S A,1987,84(24):8879-8882.
［23］Mandell JW, Glass G, Gianchandani EP, et al. Dephosphorylation of beta-arrestin 1 in glioblastomas ［J］. J Neuropathol Exp Neurol, 2009, 68(5):535-541.
［24］Jansen M, Yip S, Louis DN. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers［J］.Lancet Neurol, 2010,9(7):717-726.
［25］Rubin JB, Kung AL, Klein RS, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors［J］. Proc Natl Acad Sci USA, 2003,100 (23): 13513-13518.
［26］Gravel S, Malouf C, Boulais PE, et al. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains［J］. J Biol Chem, 2010, 285(49):37939-37943.
［27］Hartmann C, Hentschel B, Tatagiba M,et al. Molecular markers in low-grade gliomas: predictive or prognostic ［J］ ?Clin Cancer Res,2011,17(13):4588-4599.